Preston Pituitary Meeting- 9th Dec 2009

Preston Pituitary Meeting
Royal Preston Hospital
Lecture Hall Education centre 1
Wednesday 9th December 2009


12.00-13.45 Lunch

Pituitary disease during adolescence and young adulthood
Dr Helena Gleeson, Consultant endocrinologist, MRI

Endocrine outcomes of pituitary surgery at Royal Preston Hospital
Dr Sanjay Dissanayake, Endocrine SpR, Royal Preston Hospital

Coffee Break

Pituitary Gamma Knife: technique, efficacy, when and in whom to use
Dr John Newell-Price
Consultant endocrinologist, Royal Hallamshire Hospital, Sheffield

Pituitary case presentations
Chair Dr Simon Howell
Consultant endocrinologist, Royal Preston Hospital

For Further Information please contact
Alex Houston on 01772 524919
e-mail –
3 CPD points: Approval sought from the Royal College of Physicians

Dr Simon Howell

North west diabetes and Endocrine Spr teaching day- 22/10/09

Diabetes/Endocrinology SpR Clinical Training Day
Thursday 22nd October 2009
Nowgen Centre, 29 Grafton St, M13 9WU.
Next to Manchester Royal Infirmary’s main entrance facing the entrance of Grafton streets car park

0900 Registration, Tea and Coffee
0930-1020 An update on osteoporosis: guidelines and management
Dr Peter Selby, Consultant Physician & Senior Lecturer, Central Manchester University Hospital Foundation Trust.
10:20-11:10 Vitamin D and Bone in health & disease: An overview
Dr Michael Davis, Consultant Physician, Central Manchester University Hospitals Foundation Trust.
1110-1130 Tea/Coffee
1130-1220 Is there a role for bone markers and biochemistry in diagnosis and management of metabolic bone disease?
Professor William D Fraser, Liverpool University
1220-1250 Journal club: Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009 Aug 20;361(8):756-65.
Dr Seleena Farook, SpR in Endocrinology and Diabetes
1250-1320 Case presentation
Dr Clair Higham, SpR in Endocrinology and Diabetes.
1320-1410 Lunch
1410-1500 Management of osteoporosis: Recent advances in interventional radiology.
Dr Richard Whitehouse, Consultant Radiologist, Central Manchester University Hospitals 1500-1530 Journal club: A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009 Aug 6;361(6):569-79.
Dr Simeen Akhtar, SpR in Endocrinology and Diabetes.
1530-1550 Tea
1550-1630 Beast cancer treatment and steroid therapy: when and how to protect bone health?
Caroline Jagger, Osteoporosis specialist nurse, Manchester Royal Infirmary.
1630-1700 Introduction of the new specialist trainees.
Discussion: how to improve the teaching program?

YDF Diabetes Foundation Course 2009

YDF Diabetes Foundation Course

The YDF Diabetes Foundation Course, led by Dr Gerry Rayman (Ipswich), is to be held from over 3 days from 3-6th December 2009 at the Peterborough Marriott Hotel.

This is an excellent course particularly aimed at StR/SpR’s in their first couple of years training, offering the opportunity to discuss and develop skills in managing common scenarios that would typically be seen on the wards and in outpatients.
The course, supported by experienced clinicians and diabetes nurses, is case based and attendees are encouraged to bring their own experiences, questions and scenarios for open discussion amongst the gro

See the YDF website (link above) for further information.

SFE BES 2010 in Manchester, deadline for abstract submission is 16 November,2009.

The Society for Endocrinology BES 2010 meeting will take place at the Manchester Central Convention Complex in Manchester on 15-18 March 2010. The conference promises an exciting scientific programme packed with oral communications, clinical expert sessions, medal lectures and much more.

Dates for your diaries:

Abstract submission deadline: 16 November 2009


Earlybird registration deadline: 18 January 2010

Free SfE BES places for trainees: applications open 2 November-4 December 2009

Further information and the preliminary programme are now available at the website below. If you have any queries please contact the conferences department at:

Exenatide efficacy and safety: a systematic review

Exenatide efficacy and safety: a systematic review

A systematic review published in diabetic medicine performed as part of the Drug Effectiveness Review Project examining the efficacy, effectiveness and side effects of exenatide therapy. In total 17 studies were included. Overall exenatide was associated with a reduction in HbA1c of approximately 1%, similar to the introduction of another oral agent or insulin but with the benefit of weight loss.